Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Revenue
Burning Rock Biotech Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Revenue
¥563.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Revenue
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Revenue
¥4.6B
|
CAGR 3-Years
63%
|
CAGR 5-Years
201%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Revenue
¥11.2B
|
CAGR 3-Years
111%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Revenue
¥49.7B
|
CAGR 3-Years
53%
|
CAGR 5-Years
65%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Revenue
¥1.9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
Burning Rock Biotech Ltd
Revenue Breakdown
Breakdown by Geography
Burning Rock Biotech Ltd
Total Revenue:
563.2m
CNY
|
China:
553.3m
CNY
|
Breakdown by Segments
Burning Rock Biotech Ltd
Total Revenue:
563.2m
CNY
|
Central Laboratory Business:
314.8m
CNY
|
Inhospital Business:
175.3m
CNY
|
Pharma Research And Development Services:
73.2m
CNY
|
See Also
What is Burning Rock Biotech Ltd's Revenue?
Revenue
563.2m
CNY
Based on the financial report for Dec 31, 2022, Burning Rock Biotech Ltd's Revenue amounts to 563.2m CNY.
What is Burning Rock Biotech Ltd's Revenue growth rate?
Revenue CAGR 5Y
38%
Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Burning Rock Biotech Ltd have been 14% over the past three years , 38% over the past five years .